Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Lung Diseases 1 Liposarcoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Advanced Biliary Tract Cancer 1 Adenocarcinoma 1

Interventions

lenvatinib 3 Gemcitabine 3 tislelizumab 2 pembrolizumab 2 Cisplatin 2 toripalimab 1 titanium silicide 1 theasinensin A 1 surufatinib 1 sitravatinib 1 sintilimab 1 durvalumab 1 S 1 (combination) 1 Nivolumab 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Biliary Tract Cancer × sitravatinib × Clear all

NCT04727996 2024-04-19

BTC-BGB

Seoul National University Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡